Skip to ContentSkip to Navigation
Rijksuniversiteit Groningenfounded in 1614  -  top 100 university
Over ons Praktische zaken Waar vindt u ons dr. L.C.L.T. (Léon) van Kempen
University Medical Center Groningen

dr. L.C.L.T. (Léon) van Kempen

Klinisch Moleculair Bioloog in de Pathologie
Profielfoto van dr. L.C.L.T. (Léon) van Kempen
Telefoon:
050 361 5129 (Office)
Staff assistant:
050 361 0020 (Mrs. Annet Bouman - Van der Jagt)
E-mail:
l.van.kempen umcg.nl

Research interests

Clinical Scientist in Molecular Pathology, molecular diagnostic service. 

Research interests: Molecular biology and pathology of melanoma and non-small cell lung cancer. 

Publicaties

Cell-Free DNA Based Next-Generation Sequencing Does Not Differentiate Between Oligoprogression and Systemic Progression in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors-An Explorative Study

Classification of Fibro-osseous Tumors in the Craniofacial Bones using DNA Methylation and Copy Number Alterations

Detection of actionable mutations in circulating tumor DNA for non-small cell lung cancer patients

Genome-Wide DNA Methylation and Copy Number Alterations in Gastrointestinal Stromal Tumors

PDGFRA::USP8 Fusion in a Cutaneous Inflammatory Myofibroblastic Tumor, Highlighting Genetic Pleiotropy of Kinase Gene Fusions in Soft Tissue Neoplasms

Real-World Evidence of the Prevalence of Driver Mutations in Anorectal Melanoma

Serous Tubal Intraepithelial Carcinoma After Neoadjuvant Chemotherapy: A Report of 2 Cases

Developments in predictive biomarker testing and targeted therapy in advanced stage non-small cell lung cancer and their application across European countries

External Quality Assessment on Molecular Tumor Profiling with Circulating Tumor DNA-Based Methodologies Routinely Used in Clinical Pathology within the COIN Consortium

Future perspective for the application of predictive biomarker testing in advanced stage non-small cell lung cancer

Pers/media

NanoString Launches nCounter TCR Diversity Panel and Analysis Package at th

NVVP magazine 2021-01

Moleculaire diagnostiek voor de detectie van RET- en NTRK-fusies bij kanker

Successful Molecular Tumor Board

Effectiveness of the UMCG Molecular Tumor Board

Detectie van fusiegenen: kwaliteitscontrole en nieuwe methodologie

Moleculaire Tumor Boards

cBioportal at HealtRI

Opening of the Molecualr Pathology Centre, Montreal, QC, 2014

Opening of the Molecular Pathology Center, Montreal, QC, Canada, 2014